Compare Innodata Inc (INOD) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Innodata Inc vs 22nd Century Group Inc — how do they compare? Innodata Inc trades at $61.41 (market cap $2.08B), while 22nd Century Group Inc trades at $4.26 (market cap $1.56M). The key difference: Innodata Inc is far larger — about 1333.3× 22nd Century Group Inc's market cap, and Innodata Inc is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| INOD | XXII | |
|---|---|---|
Market Cap | $2.08B | $1.56M |
Sector | Technology | Technology |
52-Week High | $121.50 | $999.00 |
52-Week Low | $34.45 | $3.90 |
Enterprise Value | $1.96B | -$6.67M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INOD trades at $62.08, up 2.09% today, but faces bearish technical signals with 17 sell indicators. The stock has demonstrated strong fundamental performance with three consecutive earnings beats and robust profitability metrics including 38.57% ROE and 13.86% net margin. Recent news highlights the company's AI-driven growth momentum with a 40%+ outlook and expanding Big Tech partnerships.
Despite rich valuations (P/E 55.43), INOD's AI expansion and raised guidance present growth potential, though customer concentration and technical weakness pose risks. Analyst consensus remains bullish with a $130 price target representing 109% upside, supported by accelerating revenue growth and margin expansion in the AI services sector.
XXII trades at $4.32, down 0.23% on the day, with neutral technical signals and bearish moving averages. The company shows significant financial challenges with negative profit margins (-65.76% net income margin) and declining revenue, though analyst sentiment remains positive with 75% buy ratings. Recent corporate actions include a 20:1 reverse stock split completed in June 2026, while expansion initiatives in California and New York aim to drive VLN brand growth.
The outlook remains speculative with high execution risk given persistent losses and negative ROE (-130.19%). Investment opportunity hinges on successful commercialization of reduced-nicotine products and FDA regulatory progress, but substantial financial deterioration and competitive pressures present significant downside risk for shareholders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Innodata Inc
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
